CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 31 filers reported holding CASI PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q3 2015 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q2 2015 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q1 2015 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q4 2014 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q3 2014 | $0 | – | 45 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $12,359,000 | 22.48% |
| Consonance Capital Management LP | 10,321,956 | $15,999,000 | 1.92% |
| Wellington Shields & Co., LLC | 1,832,769 | $2,841,000 | 0.94% |
| Wellington Shields Capital Management, LLC | 2,258,264 | $3,500,000 | 0.42% |
| Ghost Tree Capital, LLC | 650,000 | $1,008,000 | 0.28% |
| Ikarian Capital, LLC | 1,268,154 | $1,966,000 | 0.16% |
| Tibra Equities Europe Ltd | 216,300 | $335,000 | 0.10% |
| 1492 Capital Management LLC | 79,743 | $124,000 | 0.06% |
| FEDERATED HERMES, INC. | 10,150,000 | $15,733,000 | 0.03% |
| Sterneck Capital Management, LLC | 40,000 | $47,000 | 0.03% |